0
0.5
1
1.5
2+
Mortality
86%
Improvement
Relative Risk
c19 early.org/va
Al-Sumiadai et al. Vitamin A for COVID-19 EARLY
Is early treatment with vitamin A beneficial for COVID-19?
Retrospective 140 patients in Iraq
Lower mortality with vitamin A (p=0.0024)
Al-Sumiadai et al., EurAsian J. Biosciences, 14:7347-7350
Favors vitamin A
Favors control
Therapeutic effect of Vitamin A on severe COVID-19 patients
Al-Sumiadai et al., EurAsian Journal of Biosciences, 14:7347-7350
Al-Sumiadai et al. , Therapeutic effect of Vitamin A on severe COVID-19 patients , EurAsian Journal of Biosciences, 14:7347-7350
Retrospective 70 severe condition patients treated with vitamin A (200,000IU for two days), salbutamol, and budesonide, and 70 patients not treated with vitamin A, showing significantly lower mortality with the addition of vitamin A.
This study is excluded in the after exclusion results of meta
analysis:
minimal details of groups provided.
risk of death, 85.7% lower , RR 0.14, p = 0.002 , treatment 2 of 70 (2.9%), control 14 of 70 (20.0%), NNT 5.8.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Al-Sumiadai et al., 31 Dec 2020, retrospective, Iraq, peer-reviewed, 3 authors.
Abstract: See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/352006870
Therapeutic effect of Vitamin A on severe COVID-19 patients
Article · December 2020
CITATION
READS
1
50
3 authors, including:
Hazim Ghazzay
University of Anbar
Wisam Zabin
4 PUBLICATIONS 1 CITATION
13 PUBLICATIONS 5 CITATIONS
SEE PROFILE
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Therapeutic effect of Vitamin A on severe COVID-19 patients View project
Diarrhea is Atypical presentation of MI View project
All content following this page was uploaded by Hazim Ghazzay on 31 May 2021.
The user has requested enhancement of the
EurAsian Journal of BioSciences
Eurasia J Biosci 14, 7347-7350 (2020)
Therapeutic effect of Vitamin A on severe COVID-19
patients
Mahmood M. Al-Sumiadai 1*, Hazim Ghazzay 2, Wisam Zabin Saleh Al-Dulaimy 3
1
DCH, Ministry of Health, Anbar Health Directorate, Ramadi City, IRAQ
F.I.C.M.S, Internal Medicine, Department of Medicine, College of Medicine, University of Anbar, IRAQ
3
CIB, Ministry of Health, Anbar Health Directorate, IRAQ
*Corresponding author: alsumaidaidrmah@gmail.com
2
Abstract
Objective: To find the effect of administration of vitamin A on patients with severe COVID-19.
Material and Methods: A cross-sectional and retrospective study was done on two groups of
patients with severe COVID-19 in isolation centers in Anbar governorate. The first group was patients
with severe COVID-19 given two doses of vitamin A (200,000 I.U.) for two days from the first day of
admission and three doses per day of salbutamol and budesonide nebulizers.. Data about the
respiratory rate and SPO2 were collected after 48 and 96 hours from the administration in addition to
the death rate among those patients. In a second group, the data was collected from files of patients
with severe COVID-19 previously admitted to isolated centers and not receiving vitamin A.
Results: A significant improvement in SPO2 and respiratory rate among severe COVID-19 patients
given vitamin A as compared to those not given vitamin A. A lower death rate was recorded among
severe COVID-19 patients who received vitamin A from those not received.
Conclusions; A great benefit of the using of vitamin A in patients with severe COVID-19. Adding
vitamin A to the regime COVID-19 therapy is recommended.
Keywords: severe COVID-19, Vitamin A, therapeutic effect
Al-Sumiadai MA, Ghazzay H, Al-Dulaimy WZH (2020) Article title Article title Article title Article title
Article title Article title Article title Article title. Eurasia J Biosci 14: 7347-7350.
© 2020 Al-Sumiadai et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit